TY - JOUR AU - Gores, G. J. PY - 2014 DA - 2014// TI - Decade in review-hepatocellular carcinoma: HCC-subtypes, stratification and sorafenib JO - Nat Rev Gastroenterol Hepatol VL - 11 UR - https://doi.org/10.1038/nrgastro.2014.157 DO - 10.1038/nrgastro.2014.157 ID - Gores2014 ER - TY - JOUR AU - Song, Y. AU - Pan, G. AU - Chen, L. AU - Ma, S. AU - Zeng, T. AU - Man Chan, T. H. PY - 2015 DA - 2015// TI - Loss of ATOH8 increases stem cell features of hepatocellular carcinoma cells JO - Gastroenterology. VL - 149 UR - https://doi.org/10.1053/j.gastro.2015.06.010 DO - 10.1053/j.gastro.2015.06.010 ID - Song2015 ER - TY - JOUR AU - Yuan, S. X. AU - Wang, J. AU - Yang, F. AU - Tao, Q. F. AU - Zhang, J. AU - Wang, L. L. PY - 2016 DA - 2016// TI - Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1 JO - Hepatology. VL - 63 UR - https://doi.org/10.1002/hep.27893 DO - 10.1002/hep.27893 ID - Yuan2016 ER - TY - JOUR AU - Necsulea, A. AU - Soumillon, M. AU - Warnefors, M. AU - Liechti, A. AU - Daish, T. AU - Zeller, U. PY - 2014 DA - 2014// TI - The evolution of lncRNA repertoires and expression patterns in tetrapods JO - Nature. VL - 505 UR - https://doi.org/10.1038/nature12943 DO - 10.1038/nature12943 ID - Necsulea2014 ER - TY - JOUR AU - Mercer, T. R. AU - Dinger, M. E. AU - Mattick, J. S. PY - 2009 DA - 2009// TI - Long non-coding RNAs: insights into functions JO - Nat Rev Genet VL - 10 UR - https://doi.org/10.1038/nrg2521 DO - 10.1038/nrg2521 ID - Mercer2009 ER - TY - JOUR AU - Fu, Z. AU - Chen, C. AU - Zhou, Q. AU - Wang, Y. AU - Zhao, Y. AU - Zhao, X. PY - 2017 DA - 2017// TI - LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9 JO - Cancer Lett VL - 410 UR - https://doi.org/10.1016/j.canlet.2017.09.019 DO - 10.1016/j.canlet.2017.09.019 ID - Fu2017 ER - TY - JOUR AU - Chen, H. AU - Ren, C. AU - Han, C. AU - Wang, D. AU - Chen, Y. AU - Fu, D. PY - 2015 DA - 2015// TI - Expression and prognostic value of miR-486-5p in patients with gastric adenocarcinoma JO - PLoS One VL - 10 UR - https://doi.org/10.1371/journal.pone.0119384 DO - 10.1371/journal.pone.0119384 ID - Chen2015 ER - TY - JOUR AU - Kim, E. AU - Kim, M. AU - Woo, D. H. AU - Shin, Y. AU - Shin, J. AU - Chang, N. PY - 2013 DA - 2013// TI - Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes Tumorigenicity of glioblastoma stem-like cells JO - Cancer Cell VL - 23 UR - https://doi.org/10.1016/j.ccr.2013.04.008 DO - 10.1016/j.ccr.2013.04.008 ID - Kim2013 ER - TY - JOUR AU - Chang, C. AU - Yang, J. AU - Xia, W. AU - Chen, C. AU - Xie, X. AU - Chao, C. PY - 2011 DA - 2011// TI - EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-β-catenin signaling JO - Cancer Cell VL - 19 UR - https://doi.org/10.1016/j.ccr.2010.10.035 DO - 10.1016/j.ccr.2010.10.035 ID - Chang2011 ER - TY - JOUR AU - Gonzalez, M. AU - Moore, H. AU - Li, X. AU - Toy, K. AU - Huang, W. AU - Sabel, M. PY - 2014 DA - 2014// TI - EZH2 expands breast stem cells through activation of NOTCH1 signaling JO - Proc Natl Acad Sci U S A VL - 111 UR - https://doi.org/10.1073/pnas.1308953111 DO - 10.1073/pnas.1308953111 ID - Gonzalez2014 ER - TY - JOUR AU - Tay, Y. AU - Rinn, J. AU - Pandolfi, P. P. PY - 2014 DA - 2014// TI - The multilayered complexity of ceRNA crosstalk and competition JO - Nature. VL - 505 UR - https://doi.org/10.1038/nature12986 DO - 10.1038/nature12986 ID - Tay2014 ER - TY - JOUR AU - Xu, L. AU - Beckebaum, S. AU - Iacob, S. AU - Wu, G. AU - Kaiser, G. M. AU - Radtke, A. PY - 2014 DA - 2014// TI - MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity JO - J Hepatol VL - 60 UR - https://doi.org/10.1016/j.jhep.2013.10.028 DO - 10.1016/j.jhep.2013.10.028 ID - Xu2014 ER - TY - JOUR AU - Zheng, F. AU - Liao, Y. AU - Cai, M. AU - Liu, T. AU - Chen, S. AU - Wu, P. PY - 2015 DA - 2015// TI - Systemic delivery of microRNA-101 potently inhibits hepatocellular carcinoma in vivo by repressing multiple targets JO - PLoS Genet VL - 11 UR - https://doi.org/10.1371/journal.pgen.1004873 DO - 10.1371/journal.pgen.1004873 ID - Zheng2015 ER - TY - JOUR AU - Ejarque, M. AU - Altirriba, J. AU - Gomis, R. AU - Gasa, R. PY - 2013 DA - 2013// TI - Characterization of the transcriptional activity of the basic helix-loop-helix (bHLH) transcription factor Atoh8 JO - Biochim Biophys Acta VL - 1829 UR - https://doi.org/10.1016/j.bbagrm.2013.08.003 DO - 10.1016/j.bbagrm.2013.08.003 ID - Ejarque2013 ER - TY - JOUR AU - Cedar, H. AU - Bergman, Y. PY - 2009 DA - 2009// TI - Linking DNA methylation and histone modification: patterns and paradigms JO - Nat Rev Genet VL - 10 UR - https://doi.org/10.1038/nrg2540 DO - 10.1038/nrg2540 ID - Cedar2009 ER - TY - STD TI - Lo Re O, Fusilli C, Rappa F, Van Haele M, Douet J, Pindjakova J, et al. Induction of cancer cell stemness by depletion of macrohistone H2A1 in hepatocellular carcinoma. Hepatology. 2018;67:636–50. ID - ref16 ER - TY - JOUR AU - Chen, H. A. AU - Kuo, T. C. AU - Tseng, C. F. AU - Ma, J. T. AU - Yang, S. T. AU - Yen, C. J. PY - 2016 DA - 2016// TI - Angiopoietin-like protein 1 antagonizes MET receptor activity to repress sorafenib resistance and cancer stemness in hepatocellular carcinoma JO - Hepatology. VL - 64 UR - https://doi.org/10.1002/hep.28773 DO - 10.1002/hep.28773 ID - Chen2016 ER - TY - JOUR AU - O'Connor, M. L. AU - Xiang, D. AU - Shigdar, S. AU - Macdonald, J. AU - Li, Y. AU - Wang, T. PY - 2014 DA - 2014// TI - Cancer stem cells: a contentious hypothesis now moving forward JO - Cancer Lett VL - 344 UR - https://doi.org/10.1016/j.canlet.2013.11.012 DO - 10.1016/j.canlet.2013.11.012 ID - O'Connor2014 ER - TY - JOUR AU - Wu, J. AU - Crowe, D. L. PY - 2015 DA - 2015// TI - The histone methyltransferase EZH2 promotes mammary stem and luminal progenitor cell expansion, metastasis and inhibits estrogen receptor-positive cellular differentiation in a model of basal breast cancer JO - Oncol Rep VL - 34 UR - https://doi.org/10.3892/or.2015.4003 DO - 10.3892/or.2015.4003 ID - Wu2015 ER - TY - JOUR AU - Suva, M. L. AU - Riggi, N. AU - Janiszewska, M. AU - Radovanovic, I. AU - Provero, P. AU - Stehle, J. C. PY - 2009 DA - 2009// TI - EZH2 is essential for glioblastoma cancer stem cell maintenance JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-09-1622 DO - 10.1158/0008-5472.CAN-09-1622 ID - Suva2009 ER - TY - JOUR AU - Jin, X. AU - Kim, L. J. Y. AU - Wu, Q. AU - Wallace, L. C. AU - Prager, B. C. AU - Sanvoranart, T. PY - 2017 DA - 2017// TI - Targeting glioma stem cells through combined BMI1 and EZH2 inhibition JO - Nat Med VL - 23 ID - Jin2017 ER - TY - JOUR AU - Vire, E. AU - Brenner, C. AU - Deplus, R. AU - Blanchon, L. AU - Fraga, M. AU - Didelot, C. PY - 2006 DA - 2006// TI - The Polycomb group protein EZH2 directly controls DNA methylation JO - Nature. VL - 439 UR - https://doi.org/10.1038/nature04431 DO - 10.1038/nature04431 ID - Vire2006 ER - TY - JOUR AU - Varambally, S. AU - Dhanasekaran, S. M. AU - Zhou, M. AU - Barrette, T. R. AU - Kumar-Sinha, C. AU - Sanda, M. G. PY - 2002 DA - 2002// TI - The polycomb group protein EZH2 is involved in progression of prostate cancer JO - Nature. VL - 419 UR - https://doi.org/10.1038/nature01075 DO - 10.1038/nature01075 ID - Varambally2002 ER - TY - JOUR AU - Matsukawa, Y. AU - Semba, S. AU - Kato, H. AU - Ito, A. AU - Yanagihara, K. AU - Yokozaki, H. PY - 2006 DA - 2006// TI - Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer JO - Cancer Sci VL - 97 UR - https://doi.org/10.1111/j.1349-7006.2006.00203.x DO - 10.1111/j.1349-7006.2006.00203.x ID - Matsukawa2006 ER - TY - JOUR AU - Kleer, C. G. AU - Cao, Q. AU - Varambally, S. AU - Shen, R. AU - Ota, I. AU - Tomlins, S. A. PY - 2003 DA - 2003// TI - EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells JO - Proc Natl Acad Sci U S A VL - 100 UR - https://doi.org/10.1073/pnas.1933744100 DO - 10.1073/pnas.1933744100 ID - Kleer2003 ER - TY - JOUR AU - Sudo, T. AU - Utsunomiya, T. AU - Mimori, K. AU - Nagahara, H. AU - Ogawa, K. AU - Inoue, H. PY - 2005 DA - 2005// TI - Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma JO - Br J Cancer VL - 92 UR - https://doi.org/10.1038/sj.bjc.6602531 DO - 10.1038/sj.bjc.6602531 ID - Sudo2005 ER - TY - JOUR AU - Marchesi, I. AU - Bagella, L. PY - 2016 DA - 2016// TI - Targeting enhancer of Zeste homolog 2 as a promising strategy for cancer treatment JO - World journal of clinical oncology VL - 7 UR - https://doi.org/10.5306/wjco.v7.i2.135 DO - 10.5306/wjco.v7.i2.135 ID - Marchesi2016 ER - TY - JOUR AU - Gan, L. AU - Xu, M. AU - Hua, R. AU - Tan, C. AU - Zhang, J. AU - Gong, Y. PY - 2018 DA - 2018// TI - The polycomb group protein EZH2 induces epithelial-mesenchymal transition and pluripotent phenotype of gastric cancer cells by binding to PTEN promoter JO - J Hematol Oncol VL - 11 UR - https://doi.org/10.1186/s13045-017-0547-3 DO - 10.1186/s13045-017-0547-3 ID - Gan2018 ER - TY - JOUR AU - Patel, N. AU - Varghese, J. AU - Masaratana, P. AU - Latunde-Dada, G. O. AU - Jacob, M. AU - Simpson, R. J. PY - 2014 DA - 2014// TI - The transcription factor ATOH8 is regulated by erythropoietic activity and regulates HAMP transcription and cellular pSMAD1,5,8 levels JO - Br J Haematol VL - 164 UR - https://doi.org/10.1111/bjh.12649 DO - 10.1111/bjh.12649 ID - Patel2014 ER -